Kymera Therapeutics, Inc. - Common Stock (KYMR)
CUSIP: 501575104
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,235,145
- Total 13F shares
- 26,479,657
- Share change
- +3,675,751
- Total reported value
- $1,284,263,574
- Price per share
- $48.50
- Number of holders
- 109
- Value change
- +$188,105,374
- Number of buys
- 80
- Number of sells
- 39
Quarterly Holders Quick Answers
What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501575104:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3.3%
|
2,630,658
|
$102,227,000 | — | 31 Mar 2021 | |
| Redmile Group, LLC |
13F
|
Company |
3.2%
|
2,603,139
|
$101,158,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
2.9%
|
2,352,338
|
$91,411,000 | — | 31 Mar 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.4%
|
1,959,211
|
$76,135,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
1,732,345
|
$67,318,000 | — | 31 Mar 2021 | |
| Deer IX & Co. Ltd. |
13F
|
Company |
2.1%
|
1,660,471
|
$64,526,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
1,513,923
|
$58,831,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
936,915
|
$36,409,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
932,978
|
$36,256,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.83%
|
669,293
|
$26,009,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.77%
|
621,777
|
$24,162,000 | — | 31 Mar 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.6%
|
479,605
|
$18,637,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.5%
|
397,708
|
$15,454,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
350,740
|
$13,630,000 | — | 31 Mar 2021 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.39%
|
313,127
|
$12,168,000 | — | 31 Mar 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.33%
|
260,920
|
$10,139,000 | — | 31 Mar 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.31%
|
250,000
|
$9,715,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.31%
|
247,527
|
$9,619,000 | — | 31 Mar 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.23%
|
186,701
|
$7,255,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
186,658
|
$7,253,000 | — | 31 Mar 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
150,332
|
$5,842,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
127,727
|
$4,963,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
124,725
|
$4,847,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
117,501
|
$4,566,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.12%
|
100,000
|
$3,886,000 | — | 31 Mar 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.12%
|
100,000
|
$3,886,000 | — | 31 Mar 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
99,365
|
$3,861,000 | — | 31 Mar 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.08%
|
64,310
|
$2,499,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
63,685
|
$2,475,000 | — | 31 Mar 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
62,740
|
$2,439,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
62,448
|
$2,427,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
58,857
|
$2,287,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.06%
|
51,810
|
$2,013,000 | — | 31 Mar 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
40,394
|
$1,570,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
39,494
|
$1,534,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
38,429
|
$1,493,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
38,336
|
$1,489,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
32,355
|
$1,257,000 | — | 31 Mar 2021 | |
| Penn Mutual Asset Management |
13F
|
Company |
0.04%
|
30,327
|
$1,179,000 | — | 31 Mar 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.04%
|
28,116
|
$1,093,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
26,599
|
$1,034,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
25,442
|
$989,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
25,200
|
$979,000 | — | 31 Mar 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
24,917
|
$968,000 | — | 31 Mar 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
24,684
|
$951,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.03%
|
22,030
|
$856,000 | — | 31 Mar 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
18,037
|
$701,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
17,800
|
$692,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
15,204
|
$591,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
14,698
|
$571,000 | — | 31 Mar 2021 |
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q2 2021
As of 30 Jun 2021,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,479,657 shares.
The largest 10 holders included
BVF INC/IL, Redmile Group, LLC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Deer IX & Co. Ltd., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
94
Q2 2021 holders
109
Holder diff
15
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.